Summit Therapeutics, Inc. (SMMT)
17.61
+0.48
(+2.80%)
USD |
NASDAQ |
Sep 04, 16:00
17.59
-0.02
(-0.11%)
After-Hours: 20:00
Summit Therapeutics Market Cap : 13.97B for Sept. 4, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 03, 2026 | 13.59B |
| September 02, 2026 | 11.58B |
| September 01, 2026 | 11.23B |
| August 31, 2026 | 10.80B |
| August 28, 2026 | 10.89B |
| August 27, 2026 | 11.37B |
| August 26, 2026 | 11.29B |
| August 25, 2026 | 10.60B |
| August 24, 2026 | 10.10B |
| August 21, 2026 | 10.44B |
| August 20, 2026 | 9.858B |
| August 19, 2026 | 10.40B |
| August 18, 2026 | 10.17B |
| August 17, 2026 | 10.14B |
| August 14, 2026 | 10.59B |
| August 13, 2026 | 11.10B |
| August 12, 2026 | 11.98B |
| August 11, 2026 | 11.99B |
| August 10, 2026 | 11.79B |
| August 07, 2026 | 11.07B |
| August 06, 2026 | 10.74B |
| August 05, 2026 | 10.73B |
| August 04, 2026 | 10.91B |
| August 03, 2026 | 10.35B |
| July 31, 2026 | 10.33B |
| Date | Value |
|---|---|
| July 30, 2026 | 10.66B |
| July 29, 2026 | 10.15B |
| July 28, 2026 | 9.954B |
| July 27, 2026 | 10.39B |
| July 24, 2026 | 10.83B |
| July 23, 2026 | 11.88B |
| July 22, 2026 | 11.69B |
| July 21, 2026 | 11.60B |
| July 20, 2026 | 10.48B |
| July 17, 2026 | 10.72B |
| July 16, 2026 | 10.68B |
| July 15, 2026 | 11.69B |
| July 14, 2026 | 12.00B |
| July 13, 2026 | 11.87B |
| July 10, 2026 | 11.83B |
| July 09, 2026 | 12.01B |
| July 08, 2026 | 12.18B |
| July 07, 2026 | 12.32B |
| July 06, 2026 | 12.36B |
| July 02, 2026 | 11.97B |
| July 01, 2026 | 11.16B |
| June 30, 2026 | 11.31B |
| June 29, 2026 | 11.11B |
| June 26, 2026 | 10.87B |
| June 25, 2026 | 11.00B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| NovelStem International Corp. | 0.4687M |
| Brainstorm Cell Therapeutics, Inc. | 11.81M |
| Kezar Life Sciences, Inc. | 53.76M |
| Protara Therapeutics, Inc. | 233.38M |
| Clene, Inc. | 49.20M |
Market Cap Related Metrics
| PEG Ratio | -1.416 |
| Price to Book Value | 22.17 |
| Price | 17.61 |
| Earnings Yield | -6.36% |
| PEGY Ratio | -1.416 |